C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 221/06 (2006.01) A61K 31/47 (2006.01) A61K 31/495 (2006.01) A61K 31/53 (2006.01) A61K 31/535 (2006.01) A61K 31/54 (2006.01) A61K 31/55 (2006.01) C07D 215/42 (2006.01) C07D 221/16 (2006.01) C07D 471/04 (2006.01) C07D 473/00 (2006.01) C07D 475/00 (2006.01) C07D 491/04 (2006.01) C07D 495/04 (2006.01) C07D 513/04 (2006.01) C07D 519/00 (2006.01)
Patent
CA 2282112
Cholesteryl ester transfer protein inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans. 23
Deninno Michael Paul
Ruggeri Roger Benjamin
Wester Ronald Thure
Pfizer Products Inc.
Smart & Biggar
LandOfFree
Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1678388